What Happened?
New York, NY-based Phosplatin-Therapeutics Appointed Robert Fallon as President and Chief Executive Officer
Date of management change: November 15, 2017
New York, NY-based Phosplatin-Therapeutics Appointed Robert Fallon as President and Chief Executive Officer
Phosplatin Therapeutics is a private, clinical stage biopharmaceutical company founded in 2010, and funded by private investors and family investment offices in the U.S., Europe and Asia.
Robert Fallon is President and Chief Executive Officer at Phosplatin Therapeutics. Previously, Robert held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: